FI68396C - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 0-(3-amino-2-hydroxi-propyl)-amidoximderivat - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 0-(3-amino-2-hydroxi-propyl)-amidoximderivat Download PDF

Info

Publication number
FI68396C
FI68396C FI772551A FI772551A FI68396C FI 68396 C FI68396 C FI 68396C FI 772551 A FI772551 A FI 772551A FI 772551 A FI772551 A FI 772551A FI 68396 C FI68396 C FI 68396C
Authority
FI
Finland
Prior art keywords
formula
hydroxy
phenyl
compound
piperidine
Prior art date
Application number
FI772551A
Other languages
English (en)
Finnish (fi)
Other versions
FI68396B (fi
FI772551A (fi
Inventor
Kalman Takacs
Nagy Peter Literati
Nee Ajzert Ilona Kiss
Antal Simay
Matyas Szentivanyi
Sandor Virag
Nee Botos Katalin Farago
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of FI772551A publication Critical patent/FI772551A/fi
Publication of FI68396B publication Critical patent/FI68396B/fi
Application granted granted Critical
Publication of FI68396C publication Critical patent/FI68396C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/14Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
FI772551A 1976-08-27 1977-08-26 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 0-(3-amino-2-hydroxi-propyl)-amidoximderivat FI68396C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU76CI1682A HU177578B (en) 1976-08-27 1976-08-27 Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives
HUCI001682 1976-08-27

Publications (3)

Publication Number Publication Date
FI772551A FI772551A (fi) 1978-02-28
FI68396B FI68396B (fi) 1985-05-31
FI68396C true FI68396C (fi) 1985-09-10

Family

ID=10994625

Family Applications (1)

Application Number Title Priority Date Filing Date
FI772551A FI68396C (fi) 1976-08-27 1977-08-26 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 0-(3-amino-2-hydroxi-propyl)-amidoximderivat

Country Status (23)

Country Link
JP (1) JPS5350131A (de)
AT (1) AT355554B (de)
AU (1) AU521432B2 (de)
BE (1) BE858134A (de)
CA (1) CA1077506A (de)
CH (1) CH630344A5 (de)
CS (1) CS204008B2 (de)
DD (1) DD132433A5 (de)
DE (1) DE2738589A1 (de)
DK (1) DK150196C (de)
ES (1) ES462346A1 (de)
FI (1) FI68396C (de)
FR (1) FR2362845A1 (de)
GB (1) GB1582029A (de)
GR (1) GR63623B (de)
HU (1) HU177578B (de)
IL (1) IL52804A (de)
NL (1) NL187478C (de)
NO (1) NO144793C (de)
PL (1) PL107628B1 (de)
SE (1) SE435280B (de)
SU (1) SU730296A3 (de)
YU (2) YU202377A (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849522A (en) * 1983-11-03 1989-07-18 Merrell Dow Pharmaceuticals Novel alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
US5212314A (en) * 1983-11-03 1993-05-18 Merrell Dow Pharmaceuticals Inc. Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
ZA848428B (en) * 1983-11-03 1985-06-26 Merrell Pharma Inc Novel alkoxyimino ether derivatives of 5-acyl-2(1h)-pyridiones
JPH01169445A (ja) * 1987-12-25 1989-07-04 Fuji Photo Film Co Ltd 焦点距離切換えカメラ
HU207988B (en) * 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
HUT54347A (en) * 1989-01-10 1991-02-28 Chinoin Gyogyszer Es Vegyeszet Improved process for producing amidoximes
HU222994B1 (hu) * 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
HUT78139A (hu) * 1995-12-22 2000-11-28 BIOREX Kutató és Fejlesztő Rt. Készítmény, különösen a bőr öregedési folyamatainak mérséklésére
AU766831B2 (en) 1998-05-11 2003-10-23 Takeda Pharmaceutical Company Limited Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity
WO2000007580A2 (en) * 1998-08-03 2000-02-17 N-Gene Kutató Kft. Pharmaceutical compositions against autoimmune diseases
AU2003202104B8 (en) 2002-01-11 2008-10-02 Cytrx Corporation Carboxamidine derivatives and their use in the treatment of vascular diseases
HUP0303584A3 (en) 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
US20230416224A1 (en) 2020-11-19 2023-12-28 Zevra Denmark A/S Processes for preparing arimoclomol citrate and intermediates thereof

Also Published As

Publication number Publication date
FI68396B (fi) 1985-05-31
AU521432B2 (en) 1982-04-01
ATA605477A (de) 1979-08-15
NO772958L (no) 1978-02-28
NO144793B (no) 1981-08-03
CH630344A5 (en) 1982-06-15
SU730296A3 (ru) 1980-04-25
IL52804A (en) 1981-06-29
DK150196C (da) 1987-07-06
HU177578B (en) 1981-11-28
CS204008B2 (en) 1981-03-31
FI772551A (fi) 1978-02-28
NO144793C (no) 1981-11-11
JPS6216942B2 (de) 1987-04-15
IL52804A0 (en) 1977-10-31
FR2362845A1 (fr) 1978-03-24
PL107628B1 (pl) 1980-02-29
NL7709276A (nl) 1978-03-01
DK379777A (da) 1978-02-28
AU2825477A (en) 1979-03-01
DE2738589A1 (de) 1978-03-02
JPS5350131A (en) 1978-05-08
ES462346A1 (es) 1978-06-16
YU202377A (en) 1983-12-31
YU237782A (en) 1983-12-31
DK150196B (da) 1987-01-05
SE435280B (sv) 1984-09-17
GR63623B (en) 1979-11-27
NL187478C (nl) 1991-10-16
DD132433A5 (de) 1978-09-27
GB1582029A (en) 1980-12-31
BE858134A (fr) 1977-12-16
FR2362845B1 (de) 1981-01-09
AT355554B (de) 1980-03-10
SE7709482L (sv) 1978-02-28
CA1077506A (en) 1980-05-13

Similar Documents

Publication Publication Date Title
FI68396C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 0-(3-amino-2-hydroxi-propyl)-amidoximderivat
US4187220A (en) New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
EA009518B1 (ru) Соединения, модулирующие активность ppar, и способы их получения
HU207988B (en) Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
JPS6089474A (ja) モルフイナン誘導体,その製造方法,及び該化合物を含有する抗腫瘍剤
KR20130042047A (ko) 카베딜롤 인산염 및(또는) 그의 용매화물, 상응하는 조성물, 및(또는) 치료 방법
CA1288102C (en) Pyridine derivatives, their preparation and their use
US4308399A (en) O-(3-Amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
FI86175B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fenolderivat.
US5308840A (en) Substituted or unsubstituted benzhydryl heteroalkyl-substituted aminophenol compounds and pharmaceutical compositions thereof
US3141019A (en) Chaohj
US4880841A (en) Process of producing phenethylamine derivatives
NO803693L (no) 2,3-indoldion-derivater.
US4526893A (en) Isocarbostyril derivatives
FI85139B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara indolkarboxamidderivat samt deras salter.
US3850947A (en) 3-thiazol-4'-oxy-aminopropanol cardiovascular agents
US4021560A (en) 2-[(Dimethylamino)(3-pyridyl)methyl]cyclohexanol and related compounds
US4285942A (en) Cyclododecanone oximes
JPS6123178B2 (de)
US5523303A (en) Trisubstituted cycloalkane derivatives and process for the preparation thereof
EP0283147B1 (de) Labile Keto-Derivate von 3-substituierten 1-Alkylamino-2-propanolen und deren Verwendung als beta-adrenergische Blocker
US3474095A (en) Beta - morpholinoethyl - alpha - phenoxy-isobutyrate hydrochloride or citrate salt
EP0307115A1 (de) Phenolester
GB2044260A (en) New piperidine derivatives process for their preparation and their therapeutic applications
JPS6241704B2 (de)

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: CHINOIN GYOGUSZER ES VEGYESZETI TERMEKEK